Related references
Note: Only part of the references are listed.Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus
K. M. Goode et al.
HEART (2009)
The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure -: An analysis of the Candesartan in Heart failure:: Assessment of Reduction in Mortality and Morbidity (CHARM) program
Hertzel C. Gerstein et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Relation among left ventricular mass, insulin resistance, and hemodynamic parameters in type 2 diabetes
Neiko Ozasa et al.
HYPERTENSION RESEARCH (2008)
Biomarkers in heart failure
Eugene Braunwald
NEW ENGLAND JOURNAL OF MEDICINE (2008)
10-year follow-up of intensive glucose control in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review
Dean T. Eurich et al.
BMJ-BRITISH MEDICAL JOURNAL (2007)
Incidence of coronary heart disease in type 2 diabetic men and women - Impact of microvascular complications, treatment, and geographic location
Angelo Avogaro et al.
DIABETES CARE (2007)
Incidence and risk factors for stroke in type 2 diabetic patients - The DAI study
Carlo Bruno Giorda et al.
STROKE (2007)
The safety of metformin in heart failure
Felicia Roberts et al.
ANNALS OF PHARMACOTHERAPY (2007)
Glucose abnormalities and heart failure predict poor prognosis in the population-based Reykjavik Study
Inga S. Thrainsdottir et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2005)
Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding
M Mamdani et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Determinants of subclinical diabetic heart disease
ZY Fang et al.
DIABETOLOGIA (2005)
Diuretic versus α-blocker as first-step antihypertensive therapy -: Final results from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
MH Alderman
HYPERTENSION (2003)
Natural history of asymptomatic left ventricular systolic dysfunction in the community
TJ Wang et al.
CIRCULATION (2003)
National kidney foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
AS Levey et al.
ANNALS OF INTERNAL MEDICINE (2003)
The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65)
P Clarke et al.
DIABETIC MEDICINE (2003)
Glitazones and heart failure - Critical appraisal for the clinician
CH Wang et al.
CIRCULATION (2003)
Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of Copenhagen
I Raymond et al.
HEART (2003)
Peroxisome proliferator-activated receptor γ activators inhibit cardiac hypertrophy in cardiac myocytes
K Yamamoto et al.
CIRCULATION (2001)
Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study
MK Davies et al.
LANCET (2001)
Share Paper
